Selective Laser Trabeculoplasty: A First Line Treatment for Glaucoma
Available from: 3/03/2025 (AEDT)
Provider: Mivision
Activity Outline
Glaucoma is the leading cause of irreversible blindness worldwide. The goal of glaucoma treatment is to slow the progression of visual function deterioration and preserve the patient’s quality of life, all while managing treatment costs sustainably. Currently, the only proven approach to achieving this is by lowering intraocular pressure (IOP). Treatment begins with either topical medication or laser trabeculoplasty, with selective laser trabeculoplasty (SLT) now emerging as a preferred option. This article delves into SLT and highlights why it may offer advantages over topical medications, positioning it as a potentially optimal treatment and even a first-line option for managing glaucoma.
Learning Objectives
- Understand the mechanisms of selective laser trabeculoplasty (SLT),
- Understand the safety profile, repeatability, and cost effectiveness of SLT, and
- Consider SLT as an appropriate first-line treatment option for open angle glaucoma and ocular hypertension
Max CPD hours awarded: 1.25
Session Information
| Name |
|---|
| Selective Laser Trabeculoplasty: A First Line Treatment for Glaucoma |
| Clinical? |
| Yes |
| Interactive? |
| No |
| Therapeutic? |
| No |
| Duration of CPD Session/Module |
| 0.75 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 1.25 |